Skip to main content
Log in

Choledocholithiasis Can Present with Marked Transaminases Elevation: Systematic Review and Meta-Analysis

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Extreme transaminase elevation > 1000 international units per liter (IU/L) is typically caused by hepatocellular injury due to ischemia, drugs, or viral infection. Acute choledocholithiasis can also present with marked transaminase elevation mimicking severe hepatocellular injury, contrary to the presumed cholestatic pattern.

Methods

We searched PubMed/Medline, EMBASE, Cochrane Library, and Google Scholar for studies reporting the proportion of marked elevation of alanine aminotransferase (ALT) or aspartate aminotransferase (AST) > 1000 IU/L in patients with common bile duct (CBD) stones. A proportion meta-analysis with a corresponding 95% confidence interval (CI) was used to pool the proportion of patients with extreme transaminase elevation. I2 was used to examine heterogeneity. We used CMA software utilizing a random effect model for statistical analysis.

Results

Three studies (n = 1328 patients) were included in our analysis. The reported frequency of ALT or AST > 1000 IU/L in choledocholithiasis patients ranged between 6 and 9.6%, with pooled frequency of 7.8% (95% CI 5.5–10.8%, I2 61%). The frequency of patients with ALT or AST > 500 IU/L was higher, ranging between 28 and 47%, with pooled frequency of 33.1% (95% CI 25.3–42%, I2 88%).

Conclusion

This is the first meta-analysis to study prevalence of severe hepatocellular injury in patients with CBD stones. Results revealed that approximately one-third of patients with choledocholithiasis present with ALT or AST > 500 IU/L. Furthermore, levels > 1000 IU/L are not uncommon. An elaborate work-up for alternative etiologies of severe transaminase elevation is likely unwarranted in cases with clear evidence of choledocholithiasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians [Internet]. C. Can. Med. Assoc. J. 2005;172:367.

    Article  Google Scholar 

  2. Bangaru S, Thiele D, Sreenarasimhaiah J et al. Severe elevation of liver tests in choledocholithiasis: an uncommon occurrence with important clinical implications [Internet]. J. Clin. Gastroenterol. 2017;51:728–733.

    Article  PubMed  Google Scholar 

  3. Lee WM, Seremba E. Etiologies of acute liver failure [Internet]. Curr. Opin. Crit. Care 2008;14:198–201.

    Article  PubMed  Google Scholar 

  4. Xu HM, Chen Y, Xu J et al. Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase [Internet]. World J. Gastroenterol. 2012;18:5972.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Ellis G, Goldberg DM, Spooner RJ et al. Serum enzyme tests in diseases of the liver and biliary tree [Internet]. Am. J. Clin. Pathol. 1978;70:248–258.

    Article  CAS  PubMed  Google Scholar 

  6. Nathwani RA, Kumar SR, Reynolds TB et al. Marked elevation in serum transaminases: an atypical presentation of choledocholithiasis [Internet]. Am. J. Gastroenterol. 2005;100:295–298.

    Article  CAS  PubMed  Google Scholar 

  7. Björnsson HK, Olafsson S, Bergmann OM et al. A prospective study on the causes of notably raised alanine aminotransferase (ALT) [Internet]. Scand. J. Gastroenterol. 2015;51:594–600. https://doi.org/10.3109/00365521.2015.1121516.

    Article  CAS  PubMed  Google Scholar 

  8. Campos S, Silva N, Carvalho A et al. A new paradigm in gallstones diseases and marked elevation of transaminases: an observational study [Internet]. Ann. Hepatol. 2017;16:285–290.

    Article  CAS  PubMed  Google Scholar 

  9. Hoy D, Brooks P, Woolf A et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement [Internet]. J. Clin. Epidemiol. 2012;65:934–939.

    Article  PubMed  Google Scholar 

  10. Rothstein H, Sutton AJ, Borenstein M. Publication bias in meta-analysis: prevention, assessment and adjustments, Wiley; 2005; 356.

    Book  Google Scholar 

  11. Björnsson HK, Björnsson ES. A significant proportion of patients with choledocholithiasis have markedly elevated alanine aminotransferase [Internet]. Scand. J. Gastroenterol. 2019;54:1155–1159.

    Article  PubMed  Google Scholar 

  12. Ohlsson EG, Rutherford RB, Haalebos MMP et al. The effect of biliary obstruction on hepatosplanchnic blood flow in dogs [Internet]. J. Surg. Res. 1970;10:201–208.

    Article  CAS  PubMed  Google Scholar 

  13. Souza ME, Castro-e-Silva Júnior O, Picinato MA et al. Serum transaminase levels in the acute phase of chronic extrahepatic cholestasis [Internet]. Brazilian J. Med Biol. Res. Rev. Bras. Pesqui. Medicas Biol. 1990;23:995–997.

    CAS  Google Scholar 

  14. Isogai M, Hachisuka K, Yamaguchi A et al. Etiology and pathogenesis of marked elevation of serum transaminase in patients with acute gallstone disease [Internet]. HPB Surg. 1991;4:95–107.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Mossberg SM, Ross G. High serum transaminase activity associated with extrahepatic biliary disease: a clinical and pathologic study of sixty patients with serum glutamic-oxalacetic transaminase levels of 300 units or greater. Gastroenterology 1963;45:345–353.

    Article  CAS  PubMed  Google Scholar 

  16. ASGE Standards of Practice Committee, Buxbaum JL, Abbas Fehmi SM et al. ASGE guideline on the role of endoscopy in the evaluation and management of choledocholithiasis. Gastrointest Endosc. 2019;89:1075-1105.e15. https://doi.org/10.1016/j.gie.2018.10.001.

    Article  Google Scholar 

  17. Yurgaky-Sarmiento J, Otero-Regino W, Gómez-Zuleta M. Elevated transaminases: a new tool for the diagnosis of choledocholithiasis. A case control study [Internet]. Rev. Colomb. Gastroenterol. 2020;35:319–328.

    Google Scholar 

  18. Gianpiero Manes A, Paspatis G, Aabakken L et al. Endoscopic management of common bile duct stones: European society of gastrointestinal endoscopy (ESGE) guideline [Internet]. Endoscopy 2019;51:472–491. https://doi.org/10.1055/a-0862-0346.

    Article  PubMed  Google Scholar 

  19. Narula VK, Fung EC, Overby DW, Richardson W, Stefanidis D. Clinical spotlight review: management of choledocholithiasis—a sages publication. SAGES; 2021.

    Google Scholar 

Download references

Acknowledgments

None to report.

Funding

This research received no funding or financial arrangement.

Author information

Authors and Affiliations

Authors

Contributions

Conception, design: MFM. Writing the initial draft: MFM, NW, KF. Study search, review, and selection: MFM, KE, and MA. Data collection and synthesis: MFM, KE. Statistical analysis and generation of figures: MFM. Manuscript submission and handling: NW. All authors: interpretation of data, drafting, and critical revision of the article. All authors approved the final version for publication.

Corresponding author

Correspondence to Mouhand F. H. Mohamed.

Ethics declarations

Conflict of interest

None to report.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 165 kb)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mohamed, M.F.H., Elfert, K., Wadhavkar, N. et al. Choledocholithiasis Can Present with Marked Transaminases Elevation: Systematic Review and Meta-Analysis. Dig Dis Sci 68, 3428–3435 (2023). https://doi.org/10.1007/s10620-023-07981-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-023-07981-7

Keywords

Navigation